摘要
本实验用双抗体夹心ELISA法检测29例肝癌患者血清SIL—2R，并与30例健康人对照。结果显示：①肝癌病人血清SIL—2R464．75士45．9lu／ml，肝癌病人血清SIL—2R水平明显高于健康对照组（P＜0．05）。②对经手术、化疗、免疫等综合治疗有反应者Sll一2R降低，病情恶化SIL—2R升高。结论：肝癌病人机体免疫功能低下，出现免疫抑制物SIL一2R水平增高的现象，提示检测SIL—2R对临床治疗具有重要意义。
<Abstrct>The serum soluble intereukin 2 receptor (SIL- 2R)of 29 patients with carcinoma of the liver was examined with double-antidody-scandwich ELISA methed,compared with that of 30 healthy people. The result indicated that:①The serum SIL- level of the patients was significantly higher than the normal (464. 76± 45. 91u/ml, 212. 70± 54. 4u/ml,p<0. 05). ②SIL-2R level declind if the patients had reaction to the treatment,otherwise it would increase. Conclusion:The immunity function of the patients with carcinoma of the liver was low,so the level of SIL- 2R,a immuno -depressor increased,The examination of SIL- 2R was very important to the clinical treatment,
出处
《肝胆外科杂志》
1998年第2期82-83,共2页
Journal of Hepatobiliary Surgery
关键词
肝癌
白细胞介素2
SIL-2R
Carcinoma of the liver Interleukin-2 Soluble Interleukin-2 Receptor(SIL-2R)
